TY - THES A1 - Schneider, Jochen T1 - Vergleichende Analyse der patientenzentrierten Ergebnisse nach totalendoprothetischem Ersatz von Hüft- oder Kniegelenk unter Verwendung der Kurzversion des Funktionsfragebogens Bewegungsapparat XSMFA-D T1 - COMPARATIVE ANALYSIS OF PATIENT-CENTERED OUTCOME OF TOTAL HIP OR KNEE ARTHROPLASTY WITH THE HELP OF THE EXTRA SHORT MUSCULOSKELETAL FUNCTION ASSESSMENT QUESTIONAIRE XSMFA-D N2 - In dieser Studie wurden 56 Patienten mit Coxarthrose und 59 Patienten mit Gonarthrose, die sich jeweils einem totalendoprothetischen Gelenkersatz unterzogen, vor der Operation und nach einem Zeitraum von drei Monaten unter Verwendung des XSMFA-D-Fragebogens evaluiert. Bei der Auswertung der Fragebögen zeigte sich eine statistisch signifikante Verbesserung des Funktions- und des Beeinträchtigungsindex, welche jeweils bei den Coxarthrosepatienten deutlicher ausgeprägter war als bei den Gonarthrosepatienten. Bei den Patienten mit Coxarthrose und endoprothetischem Gelenkersatz verbesserte sich der Funktionsindex des XSMFA ebenso wie der Beeinträchtigungsindex. Die Funktionskapazität des FFbH-OH und auch der HHS-Gesamtscore verbesserten sich merklich. Auch die Daten des HHS zeigten im Arztteil eine Verbesserung, ebenso wie sämtliche WOMAC-Indizes sowie der WOMAC-Gesamtscore. Während sich die Gehgeschwindigkeit ebenfalls positiv entwickelte, verbesserten sich die Indizes des Arztbogens zu Gelenkschmerzen und Funktionseinschränkung merklich. Bei Patienten mit Gonarthrose waren ähnliche Änderungen nach der Operation zu verzeichnen. Auch für diese Gruppe zeigte sich in nahezu allen Parametern eine statistisch bedeutsame Verbesserung, die jedoch nicht so stark ausgeprägt war wie bei den Patienten mit Coxarthrose: Der Funktionsindex verbesserte sich ebenso wie der Beeinträchtigungsindex. Die Funktionskapazität des FFbH-OH zeigte eine deutliche Verbesserung. Deutlich rückläufige Werte im Sinne einer Verbesserung fanden sich im WOMAC-Schmerzscore. Die WOMAC-Indizes zur Steife und Funktion bildeten ebenfalls deutliche Besserungen ab. Auch der WOMAC-Gesamtscore verbesserte sich. Die Gehgeschwindigkeit reduzierte sich erwartungsgemäß. Bei der Kovarianzanalyse war der Scoreausgangswert der Parameter mit dem größten Einfluss auf das postoperative Ergebnis nach drei Monaten. Die p-Werte in Bezug zur Baseline (Scoreausgangswert) lagen bei allen Skalen der Fragebögen XSMFA-D, WOMAC und FFbH-OH durchweg in einem signifikanten Bereich. Andere Kofaktoren wie Alter, Geschlecht und Gelenk übten einen geringer ausgeprägten Einfluss aus. Für den Funktionsindex des XSMFA-D zeigte sich 3 Monate postoperativ ein tendenzieller Einfluss des Gelenkes, während für den Beeinträchtigungsindex ein signifikanter Einfluss nachgewiesen werden konnte. Auch bei der Funktionskapazität des FFbH-OH sowie beim Parameter WOMAC-Gesamtscore zeigte sich ein signifikanter Einfluss des Gelenkes. Drei Monate nach totalendoprothetischem Gelenkersatz können Patienten mit Coxarthrose eine höhere funktionelle Verbesserung erreichen als Patienten mit Gonarthrose. Analog zu anderen Studien und zur klinischen Erfahrung mit totalendoprothetisch versorgten Cox- und Gonarthrosepatienten konnte dies durch die statistische Auswertung der XSMFA-D Fragebögen bestätigt werden. Der XSMFA-D ist ein geeignetes Instrument zur Messung des patientenzentrierten Outcome. Er kann im klinischen Alltag oder als Instrument zur Qualitätssicherung uneingeschränkt empfohlen werden. N2 - This study included 56 patients with degenerativ osteoarthritis of the hip and 59 patients with degenerativ osteoarthritis of the knee, with both groups having undergone a primary total joint replacement. With the help of the XSMFA-D and other questionnaires, the postoperative course of these patients after three month was compared. The statistical analysis showed a significant improvement of both scores of the XSMFA-D. There was a greater improvement for the patients with total hip arthroplasty then for the patients with total knee arthroplasty. The greater improvement for the patients with total hip arthroplasty was also shown through the statistical analysis of the other questionnaires like WOMAC, FFbH-OH. Three month after primary total joint replacement there is a greater improvement for the patients with total hip arthroplasty then for the patients with total knee arthroplasty. Analog to other studies and the clinical experience with total hip or knee arthroplasty this could be confirmed by statistical analysis of the XSMFA-D-questionnaire. The XSMFA-D is a suitable instrument for messuring the patient-centered outcome. It can be used at the clinical routine or as an instrument of quality management. KW - XSMFA-D KW - WOMAC KW - FFbH-OH KW - Effektstärken KW - totalendoprothetischer Ersatz von Hüfte oder Knie KW - XSMFA-D KW - WOMAC KW - FFbH-OH KW - effect sizes KW - total hip or knee arthroplasty Y1 - 2006 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-17789 ER - TY - JOUR A1 - Schneider, Anna A1 - Corona, Angela A1 - Spöring, Imke A1 - Jordan, Mareike A1 - Buchholz, Bernd A1 - Maccioni, Elias A1 - Di Santo, Roberto A1 - Bodem, Jochen A1 - Tramontano, Enzo A1 - Wöhrl, Birgitta M. T1 - Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors JF - Nucleic Acids Research N2 - We analyzed a multi-drug resistant (MR) HIV-1 reverse transcriptase (RT), subcloned from a patient-derived subtype CRF02_AG, harboring 45 amino acid exchanges, amongst them four thymidine analog mutations (TAMs) relevant for high-level AZT (azidothymidine) resistance by AZTMP excision (M41L, D67N, T215Y, K219E) as well as four substitutions of the AZTTP discrimination pathway (A62V, V75I, F116Y and Q151M). In addition, K65R, known to antagonize AZTMP excision in HIV-1 subtype B was present. Although MR-RT harbored the most significant amino acid exchanges T215Y and Q151M of each pathway, it exclusively used AZTTP discrimination, indicating that the two mechanisms are mutually exclusive and that the Q151M pathway is obviously preferred since it confers resistance to most nucleoside inhibitors. A derivative was created, additionally harboring the TAM K70R and the reversions M151Q as well as R65K since K65R antagonizes excision. MR-R65K-K70R-M151Q was competent of AZTMP excision, whereas other combinations thereof with only one or two exchanges still promoted discrimination. To tackle the multi-drug resistance problem, we tested if the MR-RTs could still be inhibited by RNase H inhibitors. All MR-RTs exhibited similar sensitivity toward RNase H inhibitors belonging to different inhibitor classes, indicating the importance of developing RNase H inhibitors further as anti-HIV drugs. KW - ribonuclease H KW - HIV-1 subtype AG KW - azidothymidine KW - reverse transcriptase KW - multi-drug resistance Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166423 VL - 44 IS - 5 ER - TY - JOUR A1 - Boetzl, Fabian A. A1 - Ries, Elena A1 - Schneider, Gudrun A1 - Krauss, Jochen T1 - It’s a matter of design - how pitfall trap design affects trap samples and possible predictions JF - PeerJ N2 - Background: Pitfall traps are commonly used to assess ground dwelling arthropod communities. The effects of different pitfall trap designs on the trapping outcome are poorly investigated however they might affect conclusions drawn from pitfall trap data greatly. Methods: We tested four pitfall trap types which have been used in previous studies for their effectiveness: a simple type, a faster exchangeable type with an extended plastic rim plate and two types with guidance barriers (V- and X-shaped). About 20 traps were active for 10 weeks and emptied biweekly resulting in 100 trap samples. Results: Pitfall traps with guidance barriers were up to five times more effective than simple pitfall traps and trap samples resulted in more similar assemblage approximations. Pitfall traps with extended plastic rim plates did not only perform poorly but also resulted in distinct carabid assemblages with less individuals of small species and a larger variation. Discussion: Due to the obvious trait filtering and resulting altered assemblages, we suggest not to use pitfall traps with extended plastic rim plates. In comprehensive biodiversity inventories, a smaller number of pitfall traps with guidance barriers and a larger number of spatial replicates is of advantage, while due to comparability reasons, the use of simple pitfall traps will be recommended in most other cases. KW - biodiversity estimation KW - spiders KW - carabid beetles KW - ground dwelling predators KW - staphylinid beetles KW - sampling method KW - inventory KW - species richness Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-176870 VL - 6 IS - e5078 ER - TY - JOUR A1 - Richter, Gesa M. A1 - Kruppa, Jochen A1 - Munz, Matthias A1 - Wiehe, Ricarda A1 - Häsler, Robert A1 - Franke, Andre A1 - Martins, Orlando A1 - Jockel-Schneider, Yvonne A1 - Bruckmann, Corinna A1 - Dommisch, Henrik A1 - Schaefer, Arne S. T1 - A combined epigenome- and transcriptome-wide association study of the oral masticatory mucosa assigns CYP1B1 a central role for epithelial health in smokers JF - Clinical Epigenetics N2 - Background The oral mucosa has an important role in maintaining barrier integrity at the gateway to the gastrointestinal and respiratory tracts. Smoking is a strong environmental risk factor for the common oral inflammatory disease periodontitis and oral cancer. Cigarette smoke affects gene methylation and expression in various tissues. This is the first epigenome-wide association study (EWAS) that aimed to identify biologically active methylation marks of the oral masticatory mucosa that are associated with smoking. Results Ex vivo biopsies of 18 current smokers and 21 never smokers were analysed with the Infinium Methylation EPICBeadChip and combined with whole transcriptome RNA sequencing (RNA-Seq; 16 mio reads per sample) of the same samples. We analysed the associations of CpG methylation values with cigarette smoking and smoke pack year (SPY) levels in an analysis of covariance (ANCOVA). Nine CpGs were significantly associated with smoking status, with three CpGs mapping to the genetic region of CYP1B1 (cytochrome P450 family 1 subfamily B member 1;best p=5.5x10(-8)) and two mapping to AHRR (aryl-hydrocarbon receptor repressor; best p=5.9x10(-9)). In the SPY analysis, 61 CpG sites at 52 loci showed significant associations of the quantity of smoking with changes in methylation values. Here, the most significant association located to the gene CYP1B1, with p=4.0x10(-10). RNA-Seq data showed significantly increased expression of CYP1B1 in smokers compared to non-smokers (p=2.2x10(-14)), together with 13 significantly upregulated transcripts. Six transcripts were significantly downregulated. No differential expression was observed for AHRR. In vitro studies with gingival fibroblasts showed that cigarette smoke extract directly upregulated the expression of CYP1B1. Conclusion This study validated the established role of CYP1B1 and AHRR in xenobiotic metabolism of tobacco smoke and highlights the importance of epigenetic regulation for these genes. For the first time, we give evidence of this role for the oral masticatory mucosa. KW - EWAS KW - Methylation KW - Expression KW - Masticatory mucosa KW - CYP1B1 KW - AHRR KW - Cytochrome P 450 pathway KW - OSCC KW - Smoking Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-226175 VL - 11 ER - TY - JOUR A1 - Dainese, Matteo A1 - Schneider, Gudrun A1 - Krauss, Jochen A1 - Steffan-Dewenter, Ingolf T1 - Complementarity among natural enemies enhances pest suppression JF - Scientific Reports N2 - Natural enemies have been shown to be effective agents for controlling insect pests in crops. However, it remains unclear how different natural enemy guilds contribute to the regulation of pests and how this might be modulated by landscape context. In a field exclusion experiment in oilseed rape (OSR), we found that parasitoids and ground-dwelling predators acted in a complementary way to suppress pollen beetles, suggesting that pest control by multiple enemies attacking a pest during different periods of its occurrence in the field improves biological control efficacy. The density of pollen beetle significantly decreased with an increased proportion of non-crop habitats in the landscape. Parasitism had a strong effect on pollen beetle numbers in landscapes with a low or intermediate proportion of non-crop habitats, but not in complex landscapes. Our results underline the importance of different natural enemy guilds to pest regulation in crops, and demonstrate how biological control can be strengthened by complementarity among natural enemies. The optimization of natural pest control by adoption of specific management practices at local and landscape scales, such as establishing non-crop areas, low-impact tillage, and temporal crop rotation, could significantly reduce dependence on pesticides and foster yield stability through ecological intensification in agriculture. KW - ecosystem services KW - agroecology Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158621 VL - 7 ER - TY - JOUR A1 - Avota, Elita A1 - Bodem, Jochen A1 - Chithelen, Janice A1 - Mandasari, Putri A1 - Beyersdorf, Niklas A1 - Schneider-Schaulies, Jürgen T1 - The Manifold Roles of Sphingolipids in Viral Infections JF - Frontiers in Physiology N2 - Sphingolipids are essential components of eukaryotic cells. In this review, we want to exemplarily illustrate what is known about the interactions of sphingolipids with various viruses at different steps of their replication cycles. This includes structural interactions during entry at the plasma membrane or endosomal membranes, early interactions leading to sphingolipid-mediated signal transduction, interactions with internal membranes and lipids during replication, and interactions during virus assembly and budding. Targeted interventions in sphingolipid metabolism – as far as they can be tolerated by cells and organisms – may open novel possibilities to support antiviral therapies. Human immunodeficiency virus type 1 (HIV-1) infections have intensively been studied, but for other viral infections, such as influenza A virus (IAV), measles virus (MV), hepatitis C virus (HCV), dengue virus, Ebola virus, and severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), investigations are still in their beginnings. As many inhibitors of sphingolipid metabolism are already in clinical use against other diseases, repurposing studies for applications in some viral infections appear to be a promising approach. KW - sphingolipid KW - ceramide KW - sphingosine-1-phosphate KW - plasma membrane KW - virus entry KW - virus replication KW - virus budding Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-246975 SN - 1664-042X VL - 12 ER - TY - JOUR A1 - Geiger, Nina A1 - Kersting, Louise A1 - Schlegel, Jan A1 - Stelz, Linda A1 - Fähr, Sofie A1 - Diesendorf, Viktoria A1 - Roll, Valeria A1 - Sostmann, Marie A1 - König, Eva-Maria A1 - Reinhard, Sebastian A1 - Brenner, Daniela A1 - Schneider-Schaulies, Sibylle A1 - Sauer, Markus A1 - Seibel, Jürgen A1 - Bodem, Jochen T1 - The acid ceramidase is a SARS-CoV-2 host factor JF - Cells N2 - SARS-CoV-2 variants such as the delta or omicron variants, with higher transmission rates, accelerated the global COVID-19 pandemic. Thus, novel therapeutic strategies need to be deployed. The inhibition of acid sphingomyelinase (ASM), interfering with viral entry by fluoxetine was reported. Here, we described the acid ceramidase as an additional target of fluoxetine. To discover these effects, we synthesized an ASM-independent fluoxetine derivative, AKS466. High-resolution SARS-CoV-2–RNA FISH and RTqPCR analyses demonstrate that AKS466 down-regulates viral gene expression. It is shown that SARS-CoV-2 deacidifies the lysosomal pH using the ORF3 protein. However, treatment with AKS488 or fluoxetine lowers the lysosomal pH. Our biochemical results show that AKS466 localizes to the endo-lysosomal replication compartments of infected cells, and demonstrate the enrichment of the viral genomic, minus-stranded RNA and mRNAs there. Both fluoxetine and AKS466 inhibit the acid ceramidase activity, cause endo-lysosomal ceramide elevation, and interfere with viral replication. Furthermore, Ceranib-2, a specific acid ceramidase inhibitor, reduces SARS-CoV-2 replication and, most importantly, the exogenous supplementation of C6-ceramide interferes with viral replication. These results support the hypotheses that the acid ceramidase is a SARS-CoV-2 host factor. KW - SARS-CoV-2 KW - ceramides KW - ceramidase KW - fluoxetine KW - acid sphingomyelinase Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-286105 SN - 2073-4409 VL - 11 IS - 16 ER - TY - JOUR A1 - Brenner, Daniela A1 - Geiger, Nina A1 - Schlegel, Jan A1 - Diesendorf, Viktoria A1 - Kersting, Louise A1 - Fink, Julian A1 - Stelz, Linda A1 - Schneider-Schaulies, Sibylle A1 - Sauer, Markus A1 - Bodem, Jochen A1 - Seibel, Jürgen T1 - Azido-ceramides, a tool to analyse SARS-CoV-2 replication and inhibition — SARS-CoV-2 is inhibited by ceramides JF - International Journal of Molecular Sciences N2 - Recently, we have shown that C6-ceramides efficiently suppress viral replication by trapping the virus in lysosomes. Here, we use antiviral assays to evaluate a synthetic ceramide derivative α-NH2-ω-N3-C6-ceramide (AKS461) and to confirm the biological activity of C6-ceramides inhibiting SARS-CoV-2. Click-labeling with a fluorophore demonstrated that AKS461 accumulates in lysosomes. Previously, it has been shown that suppression of SARS-CoV-2 replication can be cell-type specific. Thus, AKS461 inhibited SARS-CoV-2 replication in Huh-7, Vero, and Calu-3 cells up to 2.5 orders of magnitude. The results were confirmed by CoronaFISH, indicating that AKS461 acts comparable to the unmodified C6-ceramide. Thus, AKS461 serves as a tool to study ceramide-associated cellular and viral pathways, such as SARS-CoV-2 infections, and it helped to identify lysosomes as the central organelle of C6-ceramides to inhibit viral replication. KW - ceramides KW - SARS-CoV-2 KW - azido-ceramides KW - sphingolipids Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313581 SN - 1422-0067 VL - 24 IS - 8 ER -